Hanamura I - Search Results

1

Multiple myeloma with high-risk cytogenetics and its treatment approach.

Hanamura I. Hanamura I. Int J Hematol. 2022 Jun;115(6):762-777. doi: 10.1007/s12185-022-03353-5. Epub 2022 May 9. Int J Hematol. 2022. PMID: 35534749 Free PMC article. Review.

2

A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.

Iida S, Hanamura I, Suzuki T, Kamiya T, Kato M, Hayami Y, Miura K, Harada S, Tsuboi K, Wakita A, Akano Y, Taniwaki M, Nitta M, Ueda R. Iida S, et al. Among authors: hanamura i. Int J Hematol. 2000 Jul;72(1):85-91. Int J Hematol. 2000. PMID: 10979215

3

Improvement of splenomegaly and pancytopenia by enzyme replacement therapy against type 1 Gaucher disease: a report of sibling cases.

Tsuboi K, Iida S, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Komatsu H, Banno S, Wakita A, Nitta M, Ueda R. Tsuboi K, et al. Among authors: hanamura i. Int J Hematol. 2001 Apr;73(3):356-62. doi: 10.1007/BF02981962. Int J Hematol. 2001. PMID: 11345203

4

[Molecular pathogenesis of myeloma for the therapeutic targets].

Hanamura I. Hanamura I. Nihon Rinsho. 2007 Dec;65(12):2202-8. Nihon Rinsho. 2007. PMID: 18069261 Review. Japanese.

5

[Multiple melanoma-progress in understanding of molecular mechanism and improvement in treatment outcome with introduction of new drugs for multiple myeloma].

Hanamura I, Iida S. Hanamura I, et al. Gan To Kagaku Ryoho. 2010 May;37(5):816-21. Gan To Kagaku Ryoho. 2010. PMID: 20524255 Japanese. No abstract available.

6

[Genetic and cytogenetic abnormalities of multiple myeloma].

Hanamura I, Iida S. Hanamura I, et al. Nihon Rinsho. 2012 Apr;70 Suppl 2:126-32. Nihon Rinsho. 2012. PMID: 23133940 Japanese. No abstract available.

7

Overexpression of salivary-type amylase reduces the sensitivity to bortezomib in multiple myeloma cells.

Mizuno S, Hanamura I, Ota A, Karnan S, Narita T, Ri M, Mizutani M, Goto M, Gotou M, Tsunekawa N, Shikami M, Iida S, Hosokawa Y, Miwa H, Ueda R, Nitta M, Takami A. Mizuno S, et al. Among authors: hanamura i. Int J Hematol. 2015 Nov;102(5):569-78. doi: 10.1007/s12185-015-1859-0. Epub 2015 Sep 4. Int J Hematol. 2015. PMID: 26341959

8

Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902).

Ozaki S, Hata H, Abe M, Saitoh T, Hanamura I, Yano H, Sunami K, Kosugi H, Sawamura M, Nakazato T, Masunari T, Mori M, Takagi T, Murakami H, Shimizu K. Ozaki S, et al. Among authors: hanamura i. Ann Hematol. 2016 May;95(6):921-9. doi: 10.1007/s00277-016-2661-7. Epub 2016 Apr 5. Ann Hematol. 2016. PMID: 27044390 Clinical Trial.

9

[Multiple myeloma: update on pathophysiology and management].

Hanamura I, Iida S. Hanamura I, et al. Rinsho Ketsueki. 2018;59(5):529-538. doi: 10.11406/rinketsu.59.529. Rinsho Ketsueki. 2018. PMID: 29877243 Review. Japanese.

10

Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents.

Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A. Mizuno S, et al. Among authors: hanamura i. Bone Marrow Transplant. 2019 Oct;54(10):1595-1604. doi: 10.1038/s41409-019-0478-4. Epub 2019 Feb 19. Bone Marrow Transplant. 2019. PMID: 30783208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83 results

Search Page